Related Experiment Video
Updated: Jun 9, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
Transient neonatal diabetes mellitus type 1
Deborah J G Mackay1, I Karen Temple
1University of Southampton, UK. djgm@soton.ac.uk
Insights
Transient neonatal diabetes mellitus type 1 (TNDM1) is a rare diabetes caused by gene overexpression. It resolves in infancy but often recurs, offering insights into imprinting disorders and epigenetics in diabetes.
Area of Science:
- Genetics
- Epigenetics
- Endocrinology
Background:
- Transient neonatal diabetes mellitus type 1 (TNDM1) is a rare condition presenting in infancy, resolving, and often recurring later.
- TNDM1 results from the overexpression of imprinted genes PLAGL1 and HYMAI on chromosome 6q24.
- Gene expression is normally restricted by maternal DNA methylation, but TNDM1 involves uniparental disomy, duplication, or imprinting relaxation.
Purpose of the Study:
- To investigate the genetic and epigenetic causes of TNDM1.
- To understand the role of imprinted genes in diabetes development.
- To explore the connection between TNDM1, imprinting disorders, and broader epigenetic regulation.
Main Methods:
- Analysis of genetic and epigenetic alterations in TNDM1 patients.
- Examination of gene expression patterns at the 6q24 locus.
- Investigation of mutations in transcription factors like ZFP57.
Main Results:
- TNDM1 is linked to overexpression of PLAGL1 and HYMAI, not mutations.
- Maternal hypomethylation at the TNDM1 locus is observed in over half of patients, often with broader genomic hypomethylation.
- The majority of patients with widespread hypomethylation have ZFP57 mutations.
Conclusions:
- TNDM1 provides insights into imprinting disorder mechanisms.
- Epigenetic factors, including ZFP57 mutations and hypomethylation, play a crucial role in TNDM1.
- Further research on TNDM1 can illuminate imprinting biology and epigenetics in diabetes.
Abstract:
Transient neonatal diabetes mellitus type 1 (TNDM1) is a rare but remarkable form of diabetes which presents in infancy, resolves in the first months of life, but then frequently recurs in later life. It is caused by overexpression of the imprinted genes PLAGL1 and HYMAI on human chromosome 6q24. The expression of these genes is normally restricted to the paternal allele as a result of maternal DNA methylation. TNDM1 is not associated with mutation of PLAGL1 or HYMAI, but rather with their overexpression via uniparental disomy, chromosome duplication, or relaxation of imprinting. Study of patients with TNDM1 has provided valuable insights into the causes of imprinting disorders. Over half of patients with maternal hypomethylation at the TNDM1 locus have additional hypomethylation of other maternally methylated imprinted genes throughout the genome, and the majority of these patients have mutations in the transcription factor ZFP57. TNDM1 with maternal hypomethylation has also been observed in patients conceived by assisted reproduction, and in discordant monozygotic twins. The variable clinical features of TNDM1 may be associated with variation in the nature of the underlying epigenetic and genetic mutations, and future study of this disorder is likely to yield further insights not only into the biological mechanisms of imprinting, but also into the contribution of epigenetics to diabetes.
Related Concept Videos
Type I Diabetes I: Introduction
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Introduction
Type I Diabetes II: Pathophysiology
